MicroRNA-502-3p Modulates the GABA A Subunits, Synaptic Proteins, and Mitochondrial Morphology in Hippocampal Neurons

Bhupender Sharma1, Daniela Rodarte1, Gunjan Goyal1

  • 1Center of Emphasis in Neuroscience, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX, USA.

PubMed

Insights

MicroRNA-502-3p (miR-502-3p) impacts Alzheimer's disease by regulating synaptic function and mitochondrial health. Suppressing miR-502-3p improves neuronal mitochondria and synaptic proteins, offering therapeutic insights.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-502-3p (miR-502-3p) is implicated in Alzheimer's disease (AD) and modulates GABAergic synapse function.
  • Previous studies indicated high miR-502-3p expression in AD synapses and its regulation of GABRA1 protein.

Purpose of the Study:

  • To investigate the impact of miR-502-3p on GABA receptor subunits, synaptic proteins, and mitochondrial morphology in hippocampal neurons.
  • To explore the gene expression changes induced by miR-502-3p modulation.

Main Methods:

  • Mouse hippocampal neuronal cells (HT22) were transfected with miR-502-3p overexpression or suppression vectors.
  • Gene and protein expression analyzed via qRT-PCR, RNAscope, immunoblotting, and gene array.
  • Mitochondrial morphology assessed using transmission electron microscopy.

Main Results:

  • Elevated miR-502-3p negatively regulated Gabra1 expression.
  • miR-502-3p suppressed GABA A subunit and synaptic protein levels, while suppression increased them.
  • Mitochondrial morphology, including number, length, and area, improved upon miR-502-3p suppression.
  • Gene array identified miR-502-3p's modulation of genes involved in oxidative stress, immune response, and synaptic function.

Conclusions:

  • miR-502-3p plays a significant role in regulating neuronal function, synaptic activity, and mitochondrial health.
  • Findings offer new insights into the molecular mechanisms underlying miR-502-3p's role in neurological disorders like AD.